AIROS® Medical, Inc., a medical technology manufacturer specializing in compression therapy systems that treat ...
AUDUBON, Pa., Feb. 4, 2026 /PRNewswire/ -- AIROS® Medical, Inc., a medical technology manufacturer specializing in compression therapy systems that treat peripheral vascular disorders, today announced ...
Cardinal Health, Inc. (NYSE:CAH) Q2 2026 Earnings Call Transcript February 5, 2026 Cardinal Health, Inc. beats earnings expectations. Reported EPS is $2.63, expectations were $2.34. Operator: Hello, ...
AUDUBON, PA — AIROS® Medical, Inc. has launched its U.S. Food and Drug Administration 510(k)-cleared ARTAIRA® Arterial Compression Device, a prescription-only system designed to increase blood flow in ...
According to the American Limb Preservation Society, a 2025 global study projects an alarming 220% increase in PAD cases worldwide by 2050 to more than 360 million. PAD is a serious vascular condition ...
3-in-1 therapies (compression, vibration, and LED) to optimize recovery. Features preset routines and customizable settings. Fully wireless. Available in three sizes. Limited transparency around the ...
The team remains focused on driving Cardinal Health brand growth, where we continue to see positive results and ...
Tactile Systems Technology, Inc., a medical technology company, develops and provides medical devices to treat underserved chronic diseases in the United States. It offers Flexitouch Plus system, a ...
News-Medical.Net on MSN
Injectable clay-based bandages rapidly stop severe internal bleeding
Traumatic injury is the third leading cause of death in the state of Texas, surpassing strokes, Alzheimer's disease and diabetes, according to the Centers for Disease Control and Prevention. A massive ...
Typically, the first step in treating restless legs syndrome (RLS) is to identify the cause. Common causes of RLS can include daily habits, side effects of medications, and underlying health ...
Feb. 17, 2026 Scientists in China have unveiled a breakthrough way to mass-produce powerful cancer-fighting immune cells in the lab. By engineering early-stage stem cells from cord blood—rather than ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results